✦ LIBER ✦

Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases

✍ Scribed by Jean-Jacques Body; Alison Stopeck; Yasuhiro Fujiwara; Allan Lipton; Guenther Steger; Maria Viniegra; Michelle Fan; Roger Dansey; Jun Susie; Braun Ada

Book ID: 116322770
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 71 KB
Volume: 46
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2010.01.078

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results From a Phase 3 Randomized, Doubl

Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma

✍ Roger von Moos; David Henry; Saroj Vadhan-Raj; Vania Hungria; Andrew Spencer; Ve 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Pain outcomes in patients with advanced

Pain outcomes in patients with advanced breast cancer and bone metastases : Results from a randomized, double-blind study of denosumab and zoledronic acid

✍ Charles S. Cleeland; Jean-Jacques Body; Alison Stopeck; Roger von Moos; Lesley F 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Denosumab versus zoledronic acid (ZA) fo

Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trials

✍ A. Lipton*; A. Stopeck; R. von Moos; D. Henry; G. Richardson; G. Rodriguez; H. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Denosumab versus zoledronic acid for tre

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

✍ Karim Fizazi; Michael Carducci; Matthew Smith; Ronaldo Damião; Janet Brown; Lawr 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 840 KB

Re: Denosumab Versus Zoledronic Acid for

Re: Denosumab Versus Zoledronic Acid for Treatment of Bone Metastases in Men With Castration-Resistant Prostate Cancer: A Randomised, Double-Blind Study

✍ Walsh, Patrick C. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 110 KB

Incidence and outcomes of osteonecrosis

Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma

✍ J.E. Brown*; C.H. Barrios; I.J. Diel; T. Facon; K. Fizazi; T. Ibrahim; F. Saad; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB